A study on the fate of curcumin in the rat - PubMed (original) (raw)
A study on the fate of curcumin in the rat
B Wahlström et al. Acta Pharmacol Toxicol (Copenh). 1978 Aug.
Abstract
The uptake, distribution and excretion of curcumin in Sprague-Dawley rats has been studied. When administered orally in a dose of 1 g/kg, curcumin was excreted in the faeces to about 75%, while negligible amounts of curcumin appeared in the urine. Measurements of blood plasma levels and biliary excretion showed that curcumin was poorly absorbed from the gut. No apparent toxic effects were seen after doses of up to 5 g/kg. When intravenously injected or when added to the perfusate of the isolated liver, curcumin was actively transported into bile, against concentration gradients of several hundred times. The major part of the drug was however metabolized. In suspensions of isolated hepatocytes or liver microsomes 90% of the added curcumin was metabolized within 30 min. In view of the poor absorption, rapid metabolism and excretion of curcumin, it is unlikely that substantial concentrations of curcumin occur in the body after ingestion.
Similar articles
- Absorption and tissue distribution of curcumin in rats.
Ravindranath V, Chandrasekhara N. Ravindranath V, et al. Toxicology. 1980;16(3):259-65. doi: 10.1016/0300-483x(80)90122-5. Toxicology. 1980. PMID: 7423534 - Metabolism of curcumin--studies with [3H]curcumin.
Ravindranath V, Chandrasekhara N. Ravindranath V, et al. Toxicology. 1981-1982;22(4):337-44. doi: 10.1016/0300-483x(81)90027-5. Toxicology. 1981. PMID: 7342372 - The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat.
Holder GM, Plummer JL, Ryan AJ. Holder GM, et al. Xenobiotica. 1978 Dec;8(12):761-8. doi: 10.3109/00498257809069589. Xenobiotica. 1978. PMID: 726520 - Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
Lee J, Son J, Rhee SW, Kim DH. Lee J, et al. Xenobiotica. 2003 Jul;33(7):755-65. doi: 10.1080/0049825031000108324. Xenobiotica. 2003. PMID: 12893524 - Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats.
Cui X, Kobayashi Y, Hayakawa T, Hirano S. Cui X, et al. Toxicol Sci. 2004 Dec;82(2):478-87. doi: 10.1093/toxsci/kfh265. Epub 2004 Sep 1. Toxicol Sci. 2004. PMID: 15342953
Cited by
- Study protocol of a phase 1 clinical trial establishing the safety of intrapleural administration of liposomal curcumin: curcumin as a palliative treatment for malignant pleural effusion (IPAL-MPE).
Hocking AJ, Farrall AL, Newhouse S, Sordillo P, Greco K, Karapetis CS, Dougherty B, Klebe S. Hocking AJ, et al. BMJ Open. 2021 Mar 29;11(3):e047075. doi: 10.1136/bmjopen-2020-047075. BMJ Open. 2021. PMID: 33782024 Free PMC article. - The Role of Natural Polyphenols in the Prevention and Treatment of Cervical Cancer-An Overview.
Moga MA, Dimienescu OG, Arvatescu CA, Mironescu A, Dracea L, Ples L. Moga MA, et al. Molecules. 2016 Aug 17;21(8):1055. doi: 10.3390/molecules21081055. Molecules. 2016. PMID: 27548122 Free PMC article. Review. - Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model.
Zhang Z, Leong DJ, Xu L, He Z, Wang A, Navati M, Kim SJ, Hirsh DM, Hardin JA, Cobelli NJ, Friedman JM, Sun HB. Zhang Z, et al. Arthritis Res Ther. 2016 Jun 3;18(1):128. doi: 10.1186/s13075-016-1025-y. Arthritis Res Ther. 2016. PMID: 27260322 Free PMC article. - Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects.
Ratnatilaka Na Bhuket P, El-Magboub A, Haworth IS, Rojsitthisak P. Ratnatilaka Na Bhuket P, et al. Eur J Drug Metab Pharmacokinet. 2017 Jun;42(3):341-353. doi: 10.1007/s13318-016-0377-7. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27683187 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources